The Filings Report

Healthpeak Properties, Inc.

DOCNYSECIK 765880Real Estate / REITsfiscal year ends December74 quarters since 2008

Revenue, Q3 FY2026
$821M
+16.3% on Q3 FY2025
Net income
$17M
+114.7% on Q3 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$0.02
+111.8% on Q3 FY2025
Revenue, TTM
$3.1B
trailing four quarters
Net margin, TTM
12.3%
net income $378M
Free cash flow, TTM
—
Cash and equivalents
$514M
long-term debt $9.4B, Sep 30, 2026
Shares, 12-month change
−0.8%
690M shares, Sep 30, 2026
Buybacks, TTM
$102M
0.8% of market value
Dividends, TTM
$844M
6.3% of market value
Market value
$13.4B
at the close, buybacks

Latest quarter Q3 FY2026, filed November 3, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended September 30, 2026, Healthpeak Properties, Inc. reported revenue of $821M, +16.3% on Q3 FY2025, and net income of $17M (+114.7%). Diluted earnings per share were $0.02.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of November 3, 2026.

Revenue and net incomeRevenueNet income
−$250M$0$250M$500M$750M$1.0BQ4'22, Revenue: $524MQ4'22, Net income: $7MQ4'22Q1'23, Revenue: $526MQ1'23, Net income: $119MQ1'23Q2'23, Revenue: $545MQ2'23, Net income: $52MQ2'23Q3'23, Revenue: $556MQ3'23, Net income: $64MQ3'23Q4'23, Revenue: $554MQ4'23, Net income: $71MQ4'23Q1'24, Revenue: $607MQ1'24, Net income: $7MQ1'24Q2'24, Revenue: $696MQ2'24, Net income: $146MQ2'24Q3'24, Revenue: $700MQ3'24, Net income: $86MQ3'24Q4'24, Revenue: $698MQ4'24, Net income: $5MQ4'24Q1'25, Revenue: $703MQ1'25, Net income: $43MQ1'25Q2'25, Revenue: $694MQ2'25, Net income: $32MQ2'25Q3'25, Revenue: $706MQ3'25, Net income: −$117MQ3'25Q4'25, Revenue: $719MQ4'25, Net income: $114MQ4'25Q1'26, Revenue: $753MQ1'26, Net income: $194MQ1'26Q2'26, Revenue: $772MQ2'26, Net income: $53MQ2'26Q3'26, Revenue: $821MQ3'26, Net income: $17MQ3'26−$250M$0$250M$500M$750M$1.0BQ4'22, Revenue: $524MQ4'22, Net income: $7MQ1'23, Revenue: $526MQ1'23, Net income: $119MQ1'23Q2'23, Revenue: $545MQ2'23, Net income: $52MQ3'23, Revenue: $556MQ3'23, Net income: $64MQ3'23Q4'23, Revenue: $554MQ4'23, Net income: $71MQ1'24, Revenue: $607MQ1'24, Net income: $7MQ1'24Q2'24, Revenue: $696MQ2'24, Net income: $146MQ3'24, Revenue: $700MQ3'24, Net income: $86MQ3'24Q4'24, Revenue: $698MQ4'24, Net income: $5MQ1'25, Revenue: $703MQ1'25, Net income: $43MQ1'25Q2'25, Revenue: $694MQ2'25, Net income: $32MQ3'25, Revenue: $706MQ3'25, Net income: −$117MQ3'25Q4'25, Revenue: $719MQ4'25, Net income: $114MQ1'26, Revenue: $753MQ1'26, Net income: $194MQ1'26Q2'26, Revenue: $772MQ2'26, Net income: $53MQ3'26, Revenue: $821MQ3'26, Net income: $17MQ3'26

Net income losses drawn in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $72MQ4'22, Long-term debt: $6.5BQ4'22Q1'23, Cash and equivalents: $59MQ1'23, Long-term debt: $6.5BQ1'23Q2'23, Cash and equivalents: $104MQ2'23, Long-term debt: $6.6BQ2'23Q3'23, Cash and equivalents: $63MQ3'23, Long-term debt: $6.7BQ3'23Q4'23, Cash and equivalents: $118MQ4'23, Long-term debt: $6.9BQ4'23Q1'24, Cash and equivalents: $102MQ1'24, Long-term debt: $8.8BQ1'24Q2'24, Cash and equivalents: $107MQ2'24, Long-term debt: $8.6BQ2'24Q3'24, Cash and equivalents: $180MQ3'24, Long-term debt: $8.6BQ3'24Q4'24, Cash and equivalents: $120MQ4'24, Long-term debt: $8.7BQ4'24Q1'25, Cash and equivalents: $71MQ1'25, Long-term debt: $8.9BQ1'25Q2'25, Cash and equivalents: $89MQ2'25, Long-term debt: $9.0BQ2'25Q3'25, Cash and equivalents: $91MQ3'25, Long-term debt: $9.1BQ3'25Q4'25, Cash and equivalents: $467MQ4'25, Long-term debt: $9.8BQ4'25Q1'26, Cash and equivalents: $1.2BQ1'26, Long-term debt: $10.4BQ1'26Q2'26, Cash and equivalents: $1.6BQ2'26, Long-term debt: $10.0BQ2'26Q3'26, Cash and equivalents: $514MQ3'26, Long-term debt: $9.4BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $72MQ4'22, Long-term debt: $6.5BQ1'23, Cash and equivalents: $59MQ1'23, Long-term debt: $6.5BQ1'23Q2'23, Cash and equivalents: $104MQ2'23, Long-term debt: $6.6BQ3'23, Cash and equivalents: $63MQ3'23, Long-term debt: $6.7BQ3'23Q4'23, Cash and equivalents: $118MQ4'23, Long-term debt: $6.9BQ1'24, Cash and equivalents: $102MQ1'24, Long-term debt: $8.8BQ1'24Q2'24, Cash and equivalents: $107MQ2'24, Long-term debt: $8.6BQ3'24, Cash and equivalents: $180MQ3'24, Long-term debt: $8.6BQ3'24Q4'24, Cash and equivalents: $120MQ4'24, Long-term debt: $8.7BQ1'25, Cash and equivalents: $71MQ1'25, Long-term debt: $8.9BQ1'25Q2'25, Cash and equivalents: $89MQ2'25, Long-term debt: $9.0BQ3'25, Cash and equivalents: $91MQ3'25, Long-term debt: $9.1BQ3'25Q4'25, Cash and equivalents: $467MQ4'25, Long-term debt: $9.8BQ1'26, Cash and equivalents: $1.2BQ1'26, Long-term debt: $10.4BQ1'26Q2'26, Cash and equivalents: $1.6BQ2'26, Long-term debt: $10.0BQ3'26, Cash and equivalents: $514MQ3'26, Long-term debt: $9.4BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Healthpeak Properties, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 3, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 4, 2025YoYQ3 FY2026vs Q3 FY2025
Revenue821772753719706694703698+16.3%
Cost of revenue————292276273277—
Gross profit—————————
Research and development—————————
Selling, general and administrative2423252420212624+18.5%
Operating income—————————
Other income (expense)9271906613(3)(6)(33)−31.5%
Pretax income3459196125654054(3)−47.5%
Income tax1(1)06(1)22(14)+206.7%
Net income1753194114(117)32435+114.7%
Diluted EPS ($)0.020.080.28—(0.17)0.050.06—+111.8%
Diluted shares (millions)690690695—695695699——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Healthpeak Properties, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 3, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 4, 2025YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents5141,6271,171467918971120+464.9%
Short-term investments—————————
Total current assets—————————
Total assets22,41221,68021,61620,33619,58219,81019,81619,938+14.4%
Total current liabilities—————————
Long-term debt9,38210,03210,4239,8489,1329,0418,8778,716+2.7%
Total liabilities11,60712,18212,55612,03411,31711,22310,97210,881+2.6%
Stockholders’ equity7,8667,8457,8267,5007,5977,9288,1888,401+3.5%
Shares outstanding (millions)690690689695695695695700—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed November 3, 2026.

Healthpeak Properties, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Sep 30, 2026filed Nov 3, 2026Q2 FY2026ended Jun 30, 2026filed Aug 5, 2026Q1 FY2026ended Mar 31, 2026filed May 6, 2026Q4 FY2025ended Dec 31, 2025filed Feb 3, 2026Q3 FY2025ended Sep 30, 2025filed Oct 24, 2025Q2 FY2025ended Jun 30, 2025filed Jul 25, 2025Q1 FY2025ended Mar 31, 2025filed Apr 25, 2025Q4 FY2024ended Dec 31, 2024filed Feb 4, 2025YoYQ3 FY2026vs Q3 FY2025
Operating cash flow354361261294315363279284+12.5%
Capital expenditures—————————
Free cash flow (CFO − capex)—————————
Depreciation and amortization299283290262262266269274+14.0%
Share repurchases010010072250+482.4%
Dividends paid210210212212212212213210−0.7%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 3, 2026.

Income statement

Healthpeak Properties, Inc. income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 3, 2026FY2024ended Dec 31, 2024filed Feb 4, 2025FY2023ended Dec 31, 2023filed Feb 9, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 12, 2013FY2011ended Dec 31, 2011filed Feb 14, 2012FY2010ended Dec 31, 2010filed Feb 15, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Revenue2,8232,7002,1812,0611,8961,6451,2401,1911,8482,1291,9401,6372,1001,8801,6941,2401,1471,145954
Cost of revenue—1,075902863773783405379666738—————————
Gross profit———————————————————
Research and development———————————————————
Selling, general and administrative90979513198939397891049682103689683787468
Operating income———————————————————
Other income (expense)7023893335(29)28210780133412223131831316826(321)
Pretax income28427331550712821817683911117(4)852745491383101225132
Income tax94(10)(4)(3)(9)(5)(4)(1)4(10)(1)6(2)10241
Net income71243306500506414461,061414628(559)922971833539331132448—
Diluted EPS ($)0.100.360.560.920.930.770.092.240.881.34(1.21)2.002.131.901.291.000.401.792.70
Diluted shares (millions)696676547539539531489475469467463459456428400307275238209

Balance sheet

Healthpeak Properties, Inc. balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 3, 2026FY2024ended Dec 31, 2024filed Feb 4, 2025FY2023ended Dec 31, 2023filed Feb 9, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 12, 2013FY2011ended Dec 31, 2011filed Feb 14, 2012FY2010ended Dec 31, 2010filed Feb 15, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Cash and equivalents467120118721584480545595347182301248341,0371125896
Short-term investments———————————————————
Total current assets———————————————————
Total assets20,33619,93815,69915,77115,25815,92014,03312,71914,08815,75921,45021,33120,07619,91617,40813,33212,21011,850—
Total current liabilities———————————————————
Long-term debt9,8488,7166,8766,4986,1706,6176,2995,4777,7869,09710,9759,6638,5878,6127,635————
Total liabilities12,03410,8818,7748,4838,1118,5737,3656,2068,4949,81811,70410,3349,1459,1628,1885,1866,2516,442—
Stockholders’ equity7,5008,4016,3506,6556,5156,7346,0855,9445,3015,5489,34410,73510,72310,5519,0337,9575,7815,201—
Shares outstanding (millions)695700547547539539505478469468466461457453409371294——

Cash flow statement

Healthpeak Properties, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 3, 2026FY2024ended Dec 31, 2024filed Feb 4, 2025FY2023ended Dec 31, 2023filed Feb 9, 2024FY2022ended Dec 31, 2022filed Feb 8, 2023FY2021ended Dec 31, 2021filed Feb 9, 2022FY2020ended Dec 31, 2020filed Feb 10, 2021FY2019ended Dec 31, 2019filed Feb 13, 2020FY2018ended Dec 31, 2018filed Feb 14, 2019FY2017ended Dec 31, 2017filed Feb 13, 2018FY2016ended Dec 31, 2016filed Feb 13, 2017FY2015ended Dec 31, 2015filed Feb 9, 2016FY2014ended Dec 31, 2014filed Feb 10, 2015FY2013ended Dec 31, 2013filed Feb 11, 2014FY2012ended Dec 31, 2012filed Feb 12, 2013FY2011ended Dec 31, 2011filed Feb 14, 2012FY2010ended Dec 31, 2010filed Feb 15, 2011FY2009ended Dec 31, 2009filed Feb 12, 2010FY2008ended Dec 31, 2008filed Aug 4, 2009FY2007ended Dec 31, 2007filed Aug 4, 2009
Operating cash flow1,2521,0709569007957588468498471,2141,2221,2491,1491,035724580516569453
Capital expenditures895737775962760789677561472459385273———————
Free cash flow (CFO − capex)357334182(62)36(30)169288375755837976———————
Depreciation and amortization1,0591,057750711684554435405535568505455423354346307316312258
Share repurchases9719176813115359913———————
Dividends paid8497956576486507877206976959801,0471,002957865788591517458394

Insider activity

Form 4 filings by officers, directors and 10% owners, November 3, 2024 to November 3, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$214K
1 sales by 1 insider; officers and directors $214K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
May 29, 2026Thomas John TDirectoraward1,385$15.46$21K830,053Jun 2, 2026
May 29, 2026Thomas John TDirectortax withholding78$19.15$1K829,975Jun 2, 2026
May 29, 2026Patadia Ankit B.EVP and Treasureraward1,358$15.46$21K9,047Jun 2, 2026
May 29, 2026Patadia Ankit B.EVP and Treasurertax withholding94$19.15$2K8,953Jun 2, 2026
May 29, 2026Moses Kelvin OChief Financial Officeraward937$15.46$14K1,692Jun 2, 2026
May 29, 2026Moses Kelvin OChief Financial Officertax withholding65$19.15$1K1,627Jun 2, 2026
May 29, 2026Mabry Adam GCIOaward625$15.46$10K5,140Jun 2, 2026
May 29, 2026Mabry Adam GCIOtax withholding43$19.15$8235,097Jun 2, 2026
May 29, 2026Johnston Shawn GEVP and CAOaward1,358$15.46$21K42,336Jun 2, 2026
May 29, 2026Johnston Shawn GEVP and CAOtax withholding76$19.15$1K42,260Jun 2, 2026
May 29, 2026Brinker Scott MPresident and CEO, Directoraward1,347$15.46$21K214,802Jun 2, 2026
May 29, 2026Brinker Scott MPresident and CEO, Directortax withholding114$19.15$2K214,688Jun 2, 2026
May 12, 2026Bohn Scott RCDO and Head of Labopen-market sale10,989$19.45$214K7,636May 13, 2026
May 6, 2026Griffin R Kent JrDirectoraward9,744$0.00—90,195May 7, 2026
May 6, 2026Weiss Richard A.Directoraward9,744$0.00—79,469May 7, 2026
May 6, 2026Lias-Booker AvaDirectoraward9,744$0.00—45,305May 7, 2026
May 6, 2026Lewis Sara GrootwassinkDirectoraward9,744$0.00—56,488May 7, 2026
May 6, 2026Connor James B.Directoraward9,744$0.00—38,169May 7, 2026
May 6, 2026Cartwright Brian G.Directoraward9,744$0.00—83,490May 7, 2026
May 6, 2026Sandstrom Katherine MDirectoraward9,744$0.00—76,669May 7, 2026
Feb 16, 2026Alonso Lisa AEVP and Chief HR Officertax withholding808$16.70$13K22,271Feb 17, 2026
Feb 15, 2026Alonso Lisa AEVP and Chief HR Officertax withholding495$16.70$8K23,079Feb 17, 2026
Feb 7, 2026Thomas John TDirectortax withholding6,454$16.85$109K828,668Feb 10, 2026
Feb 7, 2026Alonso Lisa AEVP and Chief HR Officertax withholding657$16.85$11K23,574Feb 10, 2026
Feb 6, 2026Thomas John TDirectoraward23,739$0.00—835,122Feb 10, 2026

Full insider history for Healthpeak Properties, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
Healthpeak Properties, Inc., CIK 765880 on EDGAR
Extract generated
November 4, 2026
Withheld
10 line-years whose four quarters do not sum to the filed year: other income FY2009, revenue FY2010, pretax income FY2011, revenue FY2011, pretax income FY2014, revenue FY2014, pretax income FY2015, pretax income FY2017, pretax income FY2018, revenue FY2018
Repaired
8 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2010, other income FY2016, pretax income FY2016, income tax FY2017, income tax FY2018, pretax income FY2018, income tax FY2019, income tax FY2024
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: not filed
Research and development: not filed
Selling, general and administrative: GeneralAndAdministrativeExpense
Operating income: not filed
Other income (expense): NonoperatingIncomeExpense, OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: not filed
Total assets: Assets
Total current liabilities: not filed
Long-term debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationAndAmortization, DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 4, 2026.

JSON file
/data/financials/DOC.json